Efficacy and safety of tyrosine kinase inhibitors combined with sintilimab and transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma: a pooled analysis
TKIs-Sin-TACE exhibits an efficacious and safe profile for Chinese patients with BCLC stage B/C HCC. Large-scale, global multicenter randomized-controlled trials are needed to further validate these findings.
Authors
- Jin-Ming Tu
- Genlin Lu (ORCID: https://orcid.org/0009-0005-2055-7441)
- Asadullah Hussainzai
- Fei Tong (ORCID: https://orcid.org/0000-0002-9197-8260)
- Renya Jiang
Institutions
- Quzhou City People's Hospital (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/jgo-2025-431
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00